These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6616404)
41. The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma. Kiyohara E; Tamai K; Katayama I; Kaneda Y Gene Ther; 2012 Jul; 19(7):734-41. PubMed ID: 21900962 [TBL] [Abstract][Full Text] [Related]
42. Topical CpG enhances the response of murine malignant melanoma to dacarbazine. Najar HM; Dutz JP J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132 [TBL] [Abstract][Full Text] [Related]
43. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a]. Kirchner HH; Atzpodien J; Poliwoda H Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119 [TBL] [Abstract][Full Text] [Related]
44. Cyclophosphamide plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) with or without Corynebacterium parvum in metastatic malignant melanoma. Presant CA; Bartolucci AA; Smalley RV; Vogler WR Cancer; 1979 Sep; 44(3):899-905. PubMed ID: 383276 [TBL] [Abstract][Full Text] [Related]
45. [Phase II study of decarbazine (DTIC) in malignant melanoma. DTIC Research Group]. Ishihara K Gan To Kagaku Ryoho; 1986 May; 13(5):1940-5. PubMed ID: 3707154 [TBL] [Abstract][Full Text] [Related]
46. Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide. Safgren SL; Reid JM; Rios R; Ames MM J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):91-6. PubMed ID: 11318431 [TBL] [Abstract][Full Text] [Related]
47. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine. Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287 [TBL] [Abstract][Full Text] [Related]
48. Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study. Hauschild A; Dummer R; Ugurel S; Kaehler KC; Egberts F; Fink W; Both-Skalsky J; Laetsch B; Schadendorf D Cancer; 2008 Sep; 113(6):1404-11. PubMed ID: 18615619 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU). Hill GJ; Ruess R; Berris R; Philpott GW; Parkin P Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984 [TBL] [Abstract][Full Text] [Related]
50. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [TBL] [Abstract][Full Text] [Related]
51. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Serrone L; Zeuli M; Sega FM; Cognetti F J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932 [TBL] [Abstract][Full Text] [Related]
52. Combination of fibroblast interferon (HuIFN beta), carboxamide (DTIC), and cimetidine for advanced malignant melanoma. Abdi EA; McPherson TA; Tan YH J Biol Response Mod; 1986 Oct; 5(5):423-8. PubMed ID: 3772395 [TBL] [Abstract][Full Text] [Related]
53. Scheduling of combination chemotherapy for a murine melanoma, with the subrenal capsular assay. Raina S; Hill HZ; Hill GJ; Rush BF J Surg Oncol; 1984 May; 26(1):51-2. PubMed ID: 6727385 [TBL] [Abstract][Full Text] [Related]
54. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine. Stein R; Chen S; Reed L; Richel H; Goldenberg DM Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960 [TBL] [Abstract][Full Text] [Related]
55. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma. Samson MK; Baker LH; Izbicki RM; Ratanatharathorn V Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223 [TBL] [Abstract][Full Text] [Related]
56. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression. Faião-Flores F; Quincoces Suarez JA; Fruet AC; Maria-Engler SS; Pardi PC; Maria DA PLoS One; 2015; 10(3):e0118702. PubMed ID: 25742310 [TBL] [Abstract][Full Text] [Related]
57. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancers, measured by the human tumor clonogenic assay. Murakami A; Koga S; Maeta M Oncology; 1988; 45(3):236-41. PubMed ID: 3368200 [TBL] [Abstract][Full Text] [Related]
58. Fatal hepatic vascular toxicity of DTIC. Is it really a rare event? Ceci G; Bella M; Melissari M; Gabrielli M; Bocchi P; Cocconi G Cancer; 1988 May; 61(10):1988-91. PubMed ID: 3359400 [TBL] [Abstract][Full Text] [Related]